Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 54.15
+0.54 (1.01%)
At close: Sep 4, 2026
SHE:301033 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 400.85 | 368.83 | 278.44 | 230.87 | 195.25 | 153.79 |
Revenue Growth | 27.59% | 32.46% | 20.61% | 18.24% | 26.96% | 24.51% |
Gross Profit Gross Profit Growth | 315.95 | 293.22 | 220.81 | 189.29 | 163.99 | 126.5 |
Operating Income Operating Income Growth | 130.36 | 116.47 | 78.97 | 44.2 | 25.74 | 27.01 |
Net Income Net Income Growth | 122.41 | 113.13 | 78.85 | 40.88 | 35.89 | 44.71 |
Earnings Per Share EPS Growth | 1.82 | 1.69 | 1.20 | 0.62 | 0.54 | 0.79 |
EPS Growth | 27.95% | 40.83% | 93.55% | 14.82% | -31.65% | 5.33% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Implanted Medical Devices Implanted Medical Devices Growth | 356 | 271.5 | 224.59 | 189.45 | 147.6 |
Others Others Growth | 12.83 | 6.95 | 6.28 | 5.8 | 6.18 |
Total Total Growth | 368.83 | 278.44 | 230.87 | 195.25 | 153.79 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 282.56 | 305.83 | 249.78 | 219.5 | 192.02 | 385.92 |
Total Debt Total Debt Growth | 9.33 | - | 1.01 | 53.13 | 81.65 | 110.7 |
Net Cash (Debt) Net Cash Growth | 273.23 | 305.83 | 248.77 | 166.36 | 110.37 | 275.22 |
Net Cash Growth | 19.41% | 22.94% | 49.53% | 50.73% | -59.90% | 61.87% |
Net Cash Per Share Net Cash Per Share Growth | 4.06 | 4.57 | 3.79 | 2.52 | 1.66 | 4.86 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 131.55 | 139.87 | 116.38 | 107.69 | 48.31 | 66.51 |
Capital Expenditures CapEx Growth | -35.27 | -23.82 | -33.16 | -40.09 | -135.96 | -152.71 |
Free Cash Flow Free Cash Flow Growth | 96.28 | 116.05 | 83.22 | 67.6 | -87.65 | -86.2 |
Free Cash Flow Growth | -18.54% | 39.44% | 23.11% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 78.82% | 79.50% | 79.30% | 81.99% | 83.99% | 82.25% |
Operating Margin | 32.52% | 31.58% | 28.36% | 19.15% | 13.18% | 17.56% |
Pretax Margin | 34.41% | 34.21% | 33.46% | 20.80% | 20.47% | 33.55% |
Profit Margin | 30.54% | 30.67% | 28.32% | 17.71% | 18.38% | 29.08% |
FCF Margin | 24.02% | 31.46% | 29.89% | 29.28% | -44.89% | -56.05% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.700 | 0.700 | 0.600 | 0.400 | 0.200 | 0.100 |
Dividend Per Share Growth | 16.67% | 16.67% | 50.00% | 100.00% | 100.00% | - |
Dividend Yield | 1.31% | 1.05% | 1.46% | 0.95% | 0.56% | 0.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 29.78 | 39.80 | 35.28 | 70.37 | 67.88 | 90.30 |
Forward PE | - | 46.68 | 40.83 | 46.57 | - | - |
P/FCF Ratio | 37.51 | 38.80 | 33.43 | 42.55 | - | - |
PS Ratio | 9.01 | 12.21 | 9.99 | 12.46 | 12.48 | 26.26 |